Engineered to meet and exceed the stringent requirements of EN 1822 and ISO 29463, the new machinery integrates advanced scanning and classification technologies to ensure uncompromising quality and performance. Each filter produced will be accompanied by a 100% individual scan test report, validating efficiency, integrity, and compliance with global standards. Camfil’s “owning our own destiny” approach means all scanning technology and production equipment for HEPA filters are designed in-house at global R&D centers — ensuring IP control, quality assurance, and customisation flexibility, a strong differentiator in the filtration industry.
This step strengthens our ability to protect patients, researchers, and production processes that depend on clean air
“By combining rigorous testing with greater production capacity, we are ready to support critical sectors in India and beyond” said Mark Simmons, CEO, Camfil Group.
The new line is capable of producing a wide range of HEPA and ULPA filters tailored to Class ISO 5–ISO 8 environments, with applications spanning:
- Hospital operating theatres and isolation wards
- Pharmaceutical production and R&D
- Biotech and semiconductor cleanrooms
- BSL-rated containment zones
Adding this line in Manesar shows our confidence in India’s growing demand for high-performance filtration
“Together with our local team, we aim to provide more customers with the clean air they need to work safely and efficiently” said Rahul Kapoor, Managing Director, Camfil India.
With this expansion, Camfil increases its ability to deliver tested, certified filters for sectors where air quality is critical to health, safety, and performance.